ARSKX Fees and Costs — Archer Stock Fund, N/a Class

Data updated: 2026-07-29

The net expense ratio is 1.16%: a 0.50% management fee plus 0.88% other expenses, less a 0.23% fee waiver. This share class carries a redemption fee of 1.00%. In fiscal 2025 the fund paid $278 in broker commissions, 0.0011% of average net assets, and portfolio turnover was 22%.

ARSKX Fees and Expenses

Annual operating expenses and sales charges of ARSKX. Prospectus, as of December 31, 2025.

Annual operating expenses
Management fee0.50%
12b-1 fee0.00%
Other expenses0.88%
Gross expense ratio1.39%
Fee waiver−0.23%
Net expense ratio1.16%
Sales charges
Max front load—
Max deferred load—
Redemption fee1.00%
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

ARSKX Costs Over Time

On $10,000 invested in ARSKX, assuming 5% a year before costs, total costs come to $724 over 5 years, cutting the return by 1.22% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 1.16%)$122$379$657
Trading costs (broker commissions)$0$0$1
Lost growth on money paid in costs$0$19$66
Total costs$122$399$724
Value after costs$10,378$11,178$12,039
Impact on return, per year1.22%1.22%1.22%

ARSKX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending August 31, 2025.

  • Explicit cost rate (commissions ÷ average net assets): 0.0011%
  • Total broker commissions: $278
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 22%
  • Securities lending: none during the year

ARSKX Agency Brokers

Commissions paid.

BrokerAmountShare
Wells Fargo Securities, LLC$278100.00%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.